Seigo Okada

778 total citations
50 papers, 475 citations indexed

About

Seigo Okada is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Seigo Okada has authored 50 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Seigo Okada's work include Kawasaki Disease and Coronary Complications (17 papers), Congenital Heart Disease Studies (9 papers) and Coronary Artery Anomalies (8 papers). Seigo Okada is often cited by papers focused on Kawasaki Disease and Coronary Complications (17 papers), Congenital Heart Disease Studies (9 papers) and Coronary Artery Anomalies (8 papers). Seigo Okada collaborates with scholars based in Japan and United States. Seigo Okada's co-authors include Shunji Hasegawa, Hiroyuki Wakiguchi, Takashi Ichiyama, Ichiro Sonaka, Susumu Furukawa, M. Hara, Yasuo Suzuki, Shouichi Ohga, Kotaro Suzuki and Eiji Nanba and has published in prestigious journals such as The Journal of Pediatrics, Clinical & Experimental Immunology and The Pediatric Infectious Disease Journal.

In The Last Decade

Seigo Okada

44 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seigo Okada Japan 10 146 132 108 103 93 50 475
Yuanyuan Wei China 16 120 0.8× 86 0.7× 96 0.9× 328 3.2× 77 0.8× 50 716
Minoru Kino Japan 13 131 0.9× 112 0.8× 75 0.7× 124 1.2× 39 0.4× 33 440
Przemysław Kapusta Poland 14 76 0.5× 90 0.7× 78 0.7× 291 2.8× 84 0.9× 37 571
Savio D’Souza United Kingdom 7 206 1.4× 112 0.8× 178 1.6× 168 1.6× 86 0.9× 11 825
Chunyang Wang China 12 161 1.1× 130 1.0× 38 0.4× 121 1.2× 26 0.3× 39 615
Masashi Uchida Japan 12 161 1.1× 87 0.7× 56 0.5× 89 0.9× 23 0.2× 63 477
Hajnalka Szabó Hungary 13 94 0.6× 70 0.5× 122 1.1× 150 1.5× 40 0.4× 41 590
Rafet Koca Türkiye 16 112 0.8× 49 0.4× 129 1.2× 81 0.8× 45 0.5× 46 773
Luciana Neves Torres United States 15 138 0.9× 95 0.7× 215 2.0× 110 1.1× 44 0.5× 54 824

Countries citing papers authored by Seigo Okada

Since Specialization
Citations

This map shows the geographic impact of Seigo Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seigo Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seigo Okada more than expected).

Fields of papers citing papers by Seigo Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seigo Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seigo Okada. The network helps show where Seigo Okada may publish in the future.

Co-authorship network of co-authors of Seigo Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Seigo Okada. A scholar is included among the top collaborators of Seigo Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seigo Okada. Seigo Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kishi, Hiroko, Sei Kobayashi, Seigo Okada, et al.. (2025). Quantitative serum proteomics to identify candidate biomarkers of coronary artery lesions in Kawasaki disease. Pediatrics International. 67(1). e70164–e70164.
2.
Okada, Seigo, et al.. (2024). Clinical utility of gastric fluid cytokine levels in preterm infants for predicting histological chorioamnionitis. Cytokine. 180. 156642–156642. 1 indexed citations
3.
Okada, Seigo, Yasuo Suzuki, Naoki Kawaguchi, et al.. (2024). Congenital Pulmonary Lymphangiectasia Masked by Postoperative Pulmonary Venous Obstruction in an Infant with Total Anomalous Pulmonary Venous Connection. International Heart Journal. 65(2). 363–366. 2 indexed citations
4.
Okada, Seigo, et al.. (2024). Ischemia with nonobstructive coronary arteries in a patient with a history of Kawasaki disease. Journal of Cardiology Cases. 29(4). 197–200. 1 indexed citations
5.
Okada, Seigo, et al.. (2022). Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations. The Pediatric Infectious Disease Journal. 41(9). e388–e392. 1 indexed citations
6.
Okada, Seigo, et al.. (2022). Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease. Inflammation. 46(1). 480–490. 5 indexed citations
7.
Okada, Seigo, et al.. (2021). Multiple heart beats: A unique presentation of cardiac rhabdomyoma. Cardiology Journal. 28(1). 190–190. 1 indexed citations
8.
Azuma, Yoshihiro, Yasuo Suzuki, Seigo Okada, et al.. (2020). Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease. Frontiers in Pediatrics. 8. 148–148. 5 indexed citations
9.
Okada, Seigo, et al.. (2020). Kawasaki Disease Following Severe Sunburn Injury. Frontiers in Pediatrics. 8. 6–6. 8 indexed citations
10.
Muneuchi, Jun, et al.. (2019). Relationship Between Pulmonary Arterial Resistance and Compliance in Patients with Down Syndrome. Pediatric Cardiology. 40(4). 841–847. 9 indexed citations
11.
Muneuchi, Jun, Yoshie Ochiai, N Masaki, et al.. (2018). Pulmonary arterial compliance is a useful predictor of pulmonary vascular disease in congenital heart disease. Heart and Vessels. 34(3). 470–476. 8 indexed citations
12.
Okada, Seigo, et al.. (2018). Dilated cardiomyopathy due to premature ductus arteriosus constriction. Cardiology in the Young. 28(9). 1172–1174. 2 indexed citations
13.
Muneuchi, Jun, Yasutaka Nakashima, Etsuro Nanishi, et al.. (2018). Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease. International Journal of Cardiology. 271. 317–321. 12 indexed citations
14.
Okada, Seigo, et al.. (2017). Pulmonary arterial resistance and compliance in preterm infants. International Journal of Cardiology. 244. 265–270. 9 indexed citations
15.
Okada, Seigo, Atsunori Oga, Takashi Furuta, et al.. (2017). Distinct Distribution of Immunocytes in a Retropharyngeal Lymphadenopathy Associated with Kawasaki Disease: A Case Study Compared with Tonsillitis. Cardiology. 137(4). 237–243. 4 indexed citations
16.
Suzuki, Yasuo, Shunji Hasegawa, Takeshi Matsushige, et al.. (2016). Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin. International Journal of Cardiology. 214. 209–215. 42 indexed citations
17.
Hasegawa, Shunji, et al.. (2016). Two infants with tuberculid associated with Kawasaki disease. Human Vaccines & Immunotherapeutics. 12(11). 2772–2776. 7 indexed citations
18.
Okada, Seigo, et al.. (2014). A novel de novo mutation of β-cardiac myosin heavy chain gene found in a twelve-year-old boy with hypertrophic cardiomyopathy. Journal of Genetics. 93(2). 557–560. 6 indexed citations
19.
Okada, Seigo, Shunji Hasegawa, Yasuo Suzuki, et al.. (2014). Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease. Scandinavian Journal of Rheumatology. 44(3). 247–252. 8 indexed citations
20.
Okada, Seigo, Shunji Hasegawa, Hideki Hasegawa, et al.. (2013). Analysis of bronchoalveolar lavage fluid in a mouse model of bronchial asthma and H1N1 2009 infection. Cytokine. 63(2). 194–200. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026